Sign In
Buy GEHC
$68.02
-1.92 (-2.75%)
At Close: Jul 31, 2026
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
11:00am, Thursday, 10'th Oct 2024
GE Healthcare's MIM Software announces the FDA clearance of Monte Carlo Dosimetry for Theranostics, enhancing precision in personalized treatment plans.
GE HealthCare to announce third quarter 2024 results on October 30, 2024
08:00am, Tuesday, 08'th Oct 2024
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2024 financial results before the market opens on Wednesday, October 30, 2024. The GE HealthCare management team
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
02:30am, Monday, 07'th Oct 2024
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent.
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
12:35pm, Wednesday, 02'nd Oct 2024
GEHC's continued focus on innovations, acquisitions and partnerships raise optimism about the stock.
Calls of the Day: General Motors, GE Healthcare, Thermo Fisher, HealthEquity, Carmax and SharkNinja
01:19pm, Tuesday, 01'st Oct 2024
The Investment Committee debate the latest Calls Of The Day and Jim Lebenthal responds to Sarat Sethi selling out of General Motors
GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado
12:30pm, Monday, 30'th Sep 2024
GEHC's Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.
US FDA approves GE HealthCare's diagnostic drug for heart disease
06:14pm, Friday, 27'th Sep 2024
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery disease, the company said on Friday.
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease.
Analyst: Healthcare Stock Faces 2 Key Pressure Points
09:22am, Thursday, 26'th Sep 2024
Shares of GE HealthCare Technologies Inc (NASDAQ:GEHC), a spinoff of General Electric (GE) , are down 1.9% before the opening bell after a bear note from UBS.
GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch
12:01pm, Friday, 20'th Sep 2024
GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.
GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool
01:26pm, Thursday, 19'th Sep 2024
GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.
GE HealthCare introduces elevated Venue point of care ultrasound solutions and new tablet-based Venue Sprint
09:00am, Thursday, 19'th Sep 2024
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of enhanced Venue ultrasound systems and a new solution setting the pace of point-of-care ultrasound (POCUS): Venue Sp
GE HealthCare announces cash dividend for third quarter of 2024
04:50pm, Wednesday, 18'th Sep 2024
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.03 per share of Common Stock for the third quarter of 2024 payab
GE HealthCare: The Image Of More Upside Is Very Real
11:24am, Wednesday, 18'th Sep 2024
GE HealthCare Technologies has shown promising performance, with a 12% stock increase since June, outperforming the S&P 500's 2.9% rise. Despite some revenue declines in key segments, the PDx segment'
This GE HealthCare Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
09:21am, Wednesday, 18'th Sep 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
